301 related articles for article (PubMed ID: 3928152)
21. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
[TBL] [Abstract][Full Text] [Related]
22. DNA cross-linked by cisplatin: a new probe for the DNA repair defect in xeroderma pigmentosum.
Chu G; Berg P
Mol Biol Med; 1987 Oct; 4(5):277-90. PubMed ID: 3695939
[TBL] [Abstract][Full Text] [Related]
23. Differential cytotoxicity and DNA cross-linking in normal and transformed human fibroblasts treated with cis-diamminedichloroplatinum(II).
Erickson LC; Zwelling LA; Ducore JM; Sharkey NA; Kohn KW
Cancer Res; 1981 Jul; 41(7):2791-4. PubMed ID: 7195771
[TBL] [Abstract][Full Text] [Related]
24. Repair of ultraviolet light damage in a variety of human fibroblast cell strains.
Lehmann AR; Kirk-Bell S; Arlett CF; Harcourt SA; de Weerd-Kastelein EA; Keijzer W; Hall-Smith P
Cancer Res; 1977 Mar; 37(3):904-10. PubMed ID: 837385
[TBL] [Abstract][Full Text] [Related]
25. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
Fujiwara Y; Nakamura M; Yokoo S
Br J Cancer; 1993 Jun; 67(6):1285-92. PubMed ID: 8512813
[TBL] [Abstract][Full Text] [Related]
26. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.
Bodenner DL; Dedon PC; Keng PC; Borch RF
Cancer Res; 1986 Jun; 46(6):2745-50. PubMed ID: 2870800
[TBL] [Abstract][Full Text] [Related]
27. Deficiency in incisions produced by XPF at the site of a DNA interstrand cross-link in Fanconi anemia cells.
Kumaresan KR; Sridharan DM; McMahon LW; Lambert MW
Biochemistry; 2007 Dec; 46(50):14359-68. PubMed ID: 18020456
[TBL] [Abstract][Full Text] [Related]
28. Binding of nuclear proteins associated with mammalian DNA repair to the mitomycin C-DNA interstrand crosslink.
Warren AJ; Ihnat MA; Ogdon SE; Rowell EE; Hamilton JW
Environ Mol Mutagen; 1998; 31(1):70-81. PubMed ID: 9464318
[TBL] [Abstract][Full Text] [Related]
29. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
Ducore JM; Erickson LC; Zwelling LA; Laurent G; Kohn KW
Cancer Res; 1982 Mar; 42(3):897-902. PubMed ID: 7199380
[TBL] [Abstract][Full Text] [Related]
30. Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment.
Bulmer JT; Zacal NJ; Rainbow AJ
Cancer Chemother Pharmacol; 2005 Aug; 56(2):189-98. PubMed ID: 15841377
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
[TBL] [Abstract][Full Text] [Related]
32. Roles of DNA interstrand crosslinking and its repair in the induction of sister-chromatid exchange and a higher induction in Fanconi's anemia cells.
Kano Y; Fujiwara Y
Mutat Res; 1981 May; 81(3):365-75. PubMed ID: 7300843
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
Murray D; Jenkins WT; Meyn RE
Cancer Res; 1985 Dec; 45(12 Pt 1):6446-52. PubMed ID: 4063992
[TBL] [Abstract][Full Text] [Related]
34. Modulation of transcriptional activity of p53 by ultraviolet radiation: linkage between p53 pathway and DNA repair through damage recognition.
Zhu Q; Wani MA; El-Mahdy M; Wani G; Wani AA
Mol Carcinog; 2000 Aug; 28(4):215-24. PubMed ID: 10972991
[TBL] [Abstract][Full Text] [Related]
35. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.
Montine TJ; Borch RF
Cancer Res; 1988 Nov; 48(21):6017-24. PubMed ID: 2458831
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of Chinese hamster ovary cell lines sensitive to mitomycin C and bleomycin.
Robson CN; Harris AL; Hickson ID
Cancer Res; 1985 Nov; 45(11 Pt 1):5304-9. PubMed ID: 2413991
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571.
Wozniak K; Czechowska A; Blasiak J
Chem Biol Interact; 2004 Apr; 147(3):309-18. PubMed ID: 15135086
[TBL] [Abstract][Full Text] [Related]
38. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y
Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296
[TBL] [Abstract][Full Text] [Related]
39. Defective repair of mitomycin C crosslinks in Fanconi's anemia and loss in confluent normal human and xeroderma pigmentosum cells.
Fujiwara Y
Biochim Biophys Acta; 1982 Dec; 699(3):217-25. PubMed ID: 6818994
[TBL] [Abstract][Full Text] [Related]
40. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair.
Bungo M; Fujiwara Y; Kasahara K; Nakagawa K; Ohe Y; Sasaki Y; Irino S; Saijo N
Cancer Res; 1990 May; 50(9):2549-53. PubMed ID: 2158392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
